Cargando…
Drug adherence to biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept
Major advances in drug development have led to the introduction of biologic disease- modifying drugs for the treatment of rheumatoid arthritis, which has resulted in unprecedented improvement in outcomes for many patients. These agents have been found to be effective in reducing clinical signs and s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429155/ https://www.ncbi.nlm.nih.gov/pubmed/22936845 http://dx.doi.org/10.2147/PPA.S23786 |